The Sultanate of Oman is the third country worldwide to implement this project, confirming its commitment to technological ...

For the first time in Ghana’s history, the country officially joins the global eye care community in commemorating World ...

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...

Empowering choice in the pharmacological management of type 2 diabetes One in nine people worldwide lives with diabetes, with 90% affected by type 2 diabetes.1 Despite ongoing advances in therapy and ...

Fully autonomous screening for diabetic retinopathy is coming to pharmacies and other locations through a strategic ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second ...

More evidence shows a risk between GLP-1 drugs and vision risks. A study in JAMA Network Open adds more evidence linking ...

For older adults with type 2 diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with nonarteritic anterior ischemic optic neuropathy (NAION).

Aging brings wisdom, experience, and often, a host of changes — including those that affect our vision. "By the time most people reach their forties, the eye begins to undergo physiological ...